BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6116414)

  • 1. Purification and concentration of rabies virus by chromatography on chemically modified porous silicates.
    Krasilnikov IV; Aksenova TA; Mchedlishvili BV
    Acta Virol; 1981 Jul; 25(4):205-12. PubMed ID: 6116414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gel chromatographic purification of rabies virus on wide-pore glass.
    Aksenova TA; Selimov MA; Chumakov MP; Bresler SE; Katushkina NV; Kolikov VM; Mchedlishvili BV; Zhdanov SP; Koromaldi EV
    Acta Virol; 1973 Nov; 17(6):449-54. PubMed ID: 4150026
    [No Abstract]   [Full Text] [Related]  

  • 3. Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines.
    van Wezel AL; van Herwaarden JA; van de Heuvel-de Rijk EW
    Dev Biol Stand; 1979; 42():65-9. PubMed ID: 223923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The preparation of rabies virus nucleocapsid specific IgG and its purification and conjugation with peroxidase or fluorescein isothiocyanate (author's transl)].
    Atanasiu P; Tsiang H; Virat J
    Ann Microbiol (Paris); 1974; 125B(1):85-98. PubMed ID: 4619766
    [No Abstract]   [Full Text] [Related]  

  • 5. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rabies virus glycoprotein: partial purification and some properties.
    Neurath AR; Vernon SK; Wiener FP; Hartzell RW; Rubin BA
    Microbios; 1973; 7(25):7-15. PubMed ID: 4121434
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies.
    Wiktor TJ; Macfarlan RI; Foggin CM; Koprowski H
    Dev Biol Stand; 1984; 57():199-211. PubMed ID: 6526138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
    Seroka D
    Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production, purification and analysis of an experimental DNA vaccine against rabies.
    Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
    J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of rabies-specific antigens by egg yolk antibody (IgY) to the recombinant rabies virus proteins produced in Escherichia coli.
    Motoi Y; Inoue S; Hatta H; Sato K; Morimoto K; Yamada A
    Jpn J Infect Dis; 2005 Apr; 58(2):115-8. PubMed ID: 15858294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A plaque-purified rabies virus (strains V-319) derived from a vampire bat (Desmodus rotundus) in Mexico: vaccine potential.
    Bijlenga G; Hernandez-Baumgarten EM
    Cornell Vet; 1984 Apr; 74(2):155-65. PubMed ID: 6467947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified chick embryo cell (PCEC) rabies vaccine for human use. Laboratory data.
    Barth R; Gruschkau H; Jaeger O; Milcke L; Weinmann E
    Behring Inst Mitt; 1984 Nov; (76):142-54. PubMed ID: 6525146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant single-chain Fv antibody fragment-alkaline phosphatase conjugate: a novel in vitro tool to estimate rabies viral glycoprotein antigen in vaccine manufacture.
    Mousli M; Turki I; Kharmachi H; Saadi M; Dellagi K
    J Virol Methods; 2007 Dec; 146(1-2):246-56. PubMed ID: 17845821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of immunoperoxidase techniques to formalin-fixed brain tissue for the diagnosis of rabies in southern Africa.
    Last RD; Jardine JE; Smit MM; van der Lugt JJ
    Onderstepoort J Vet Res; 1994 Jun; 61(2):183-7. PubMed ID: 7541123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody characterization of rabies virus isolates from Russia, Finland and Estonia.
    Metlin AE; Cox J; Rybakov SS; Huovilainen A; Grouzdev KN; Neuvonen E
    J Vet Med B Infect Dis Vet Public Health; 2004 Mar; 51(2):94-6. PubMed ID: 15030608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus.
    Gupta PK; Sharma S; Walunj SS; Chaturvedi VK; Raut AA; Patial S; Rai A; Pandey KD; Saini M
    Vet Microbiol; 2005 Jul; 108(3-4):207-14. PubMed ID: 15916870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic and molecular characterization of field and vaccine rabies virus strains in the Russian Federation.
    Metlin AE; Rybakov SS; Gruzdev KN; Neuvonen E; Cox J; Huovilainen A
    Dev Biol (Basel); 2006; 125():33-7. PubMed ID: 16878458
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physical and antigenic structure of the rabies virus].
    Schneider LG
    MMW Munch Med Wochenschr; 1978 Mar; 120(9):279-80. PubMed ID: 306055
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification of rabies virus grown in tissue culture.
    Sokol F; Kuwert E; Wiktor TJ; Hummeler K; Koprowski H
    J Virol; 1968 Aug; 2(8):836-49. PubMed ID: 4973571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The purification and concentration of the rabies virus by a diafiltration concentration method].
    Kliushnik SIu; Mchedlishvili BV; Gribencha SV; Romanova LN; Barinskiĭ IF
    Vopr Virusol; 1991; 36(5):394-9. PubMed ID: 1803772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.